Respiratory Syncytial Virus Entry Inhibitors Targeting the F Protein

Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes

(2011) J. S. McLellan et al.   JOURNAL OF VIROLOGY

Soluble Respiratory Syncytial Virus Fusion Protein in the Fully Cleaved, Pretriggered State Is Triggered by Exposure to Low-Molarity Buffer

(2011) S. Chaiwatpongsakorn et al.   JOURNAL OF VIROLOGY

Identification of nucleolin as a cellular receptor for human respiratory syncytial virus

(2011) Farnoosh Tayyari et al.   NATURE MEDICINE

Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers

(2011) K. A. Swanson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

RSV 2010: Recent advances in research on respiratory syncytial virus and other pneumoviruses

(2011) Grada M. van Bleek et al.   VACCINE

Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years

(2011) Peter L. Collins et al.   VIRUS RESEARCH

A fluorescence polarization assay using an engineered human respiratory syncytial virus F protein as a direct screening platform

(2010) Minyoung Park et al.   ANALYTICAL BIOCHEMISTRY

Two novel fusion inhibitors of human respiratory syncytial virus

(2010) Anna Lundin et al.   ANTIVIRAL RESEARCH

Neutralization of Human Respiratory Syncytial Virus Infectivity by Antibodies and Low-Molecular-Weight Compounds Targeted against the Fusion Glycoprotein

(2010) M. Magro et al.   JOURNAL OF VIROLOGY

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

(2010) Harish Nair et al.   LANCET

The Burden of Respiratory Syncytial Virus Infection in Young Children

(2009) Caroline Breese Hall et al.   NEW ENGLAND JOURNAL OF MEDICINE

New strategies for control of respiratory syncytial virus infection

(2008) James D Nokes et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Selection of a Respiratory Syncytial Virus Fusion Inhibitor Clinical Candidate. 2. Discovery of a Morpholinopropylaminobenzimidazole Derivative (TMC353121)

(2008) Jean-François Bonfanti et al.   JOURNAL OF MEDICINAL CHEMISTRY